Christine Siu is CFO & Secretary at Eidos Therapeutics, Inc. (EIDX). They have made 9 open-market trades across 1 company since 2019, most recently 2019-12-09.
CIK 0001743029
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| EIDX | 36,470 | $4.5M |
Shares reported on the most recent Form 4, priced at the 2019-12-11 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EIDX | SELL | 2019-12-09 | 2019-12-11 | $59.66 | $1.2M | -8.6% | -16.6% | -23.1% |
| EIDX | SELL | 2019-12-03 | 2019-12-05 | $58.93 | $1.2M | +9.3% | -2.9% | -10.6% |
| EIDX | SELL | 2019-11-22 | 2019-11-22 | $54.71 | $514K | +5.5% | +8.0% | -2.9% |
| EIDX | SELL | 2019-11-21 | 2019-11-22 | $54.96 | $2.5M | +5.5% | +8.0% | -2.9% |
| EIDX | SELL | 2019-11-21 | 2019-11-22 | $55.12 | $1.4M | +5.5% | +8.0% | -2.9% |
| EIDX | SELL | 2019-07-10 | 2019-07-12 | $39.37 | $197K | -4.0% | -6.7% | -6.5% |
| EIDX | SELL | 2019-06-05 | 2019-06-07 | $29.96 | $1.0M | +5.1% | +24.0% | +42.5% |
| EIDX | SELL | 2019-04-24 | 2019-04-26 | $26.11 | $131K | -2.7% | +17.0% | +36.2% |
| EIDX | SELL | 2019-03-19 | 2019-03-21 | $19.66 | $468K | +9.0% | +13.9% | +43.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.